Literature DB >> 1765135

Antimicrobial and antiviral activity of xylosyl-methylthio-adenosine, a naturally occurring analogue of methylthio-adenosine from Doris verrucosa.

A Pani1, M E Marongiu, P Obino, M Gavagnin, P La Colla.   

Abstract

Xylosyl-methylthio-adenosine, a naturally occurring analogue of 5'-deoxy-5'-methylthio-adenosine, has been postulated to play a protective role during egg development in the mollusc Doris verrucosa. However, in vitro tests showed that this analogue is devoid of activity against fungi, bacteria and viruses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1765135     DOI: 10.1007/bf01918391

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  4 in total

1.  Synthesis and antimicrobial and cytotoxic activities of pyrrole-containing analogues of trichostatin A.

Authors:  S Massa; M Artico; F Corelli; A Mai; R Di Santo; S Cortes; M E Marongiu; A Pani; P La Colla
Journal:  J Med Chem       Date:  1990-10       Impact factor: 7.446

2.  Relative potencies of anti-herpes compounds.

Authors:  P Collins; D J Bauer
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

3.  Biosynthesis and metabolism of 9-[5'-deoxy-5'-(methylthio)-beta-D-xylofuranosyl]adenine, a novel natural analogue of methylthioadenosine.

Authors:  M Porcelli; G Cacciapuoti; G Cimino; M Gavagnin; G Sodano; V Zappia
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

4.  Systematic synthesis and biological evaluation of alpha- and beta-D-xylofuranosyl nucleosides of the five naturally occurring bases in nucleic acids and related analogues.

Authors:  G Gosselin; M C Bergogne; J de Rudder; E De Clercq; J L Imbach
Journal:  J Med Chem       Date:  1986-02       Impact factor: 7.446

  4 in total
  1 in total

Review 1.  Molluscan Compounds Provide Drug Leads for the Treatment and Prevention of Respiratory Disease.

Authors:  Kate Summer; Jessica Browne; Lei Liu; Kirsten Benkendorff
Journal:  Mar Drugs       Date:  2020-11-19       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.